The global injectable drug delivery market was valued at USD 483.5 billion in 2019 and is expected to grow to USD 2,651.3 billion by 2032, reflecting a CAGR of 13.1% from 2020 to 2032. In 2019, North America accounted for a market size of USD 172.67 billion, representing a 35.71% share.
The injectable drug delivery market is a rapidly growing segment of the pharmaceutical industry, driven by rising demand for targeted, controlled, and efficient drug administration methods. It includes technologies such as prefilled syringes, auto-injectors, and needle-free injectors, which enhance patient compliance and therapeutic outcomes. The market is expanding due to the increasing prevalence of chronic diseases, biologics development, and home-based treatment trends. Innovations in formulation and delivery devices are also contributing to safer, more convenient options for both patients and healthcare providers.
Continue reading for more details: https://www.fortunebusinessinsights.com/industry-reports/injectable-drug-delivery-market-101044
Market Segmentation
- Device Type: The market includes conventional injectables (vials and ampoules) and advanced devices (auto-injectors, prefilled syringes, pen injectors, and wearables). Prefilled syringes and auto-injectors are gaining traction due to ease of use.
- Therapeutic Application: Segments include oncology, diabetes, hormonal disorders, autoimmune diseases, and others. Oncology and diabetes dominate due to the high injection frequency and therapeutic reliance.
- Usage: Divided into curative care and others (preventive care, lifestyle-related treatments). Curative care remains the largest segment in the injectable drug delivery market.
- End User: Comprises hospitals, clinics, home care settings, and ambulatory surgical centers. Home care is growing rapidly due to the shift toward self-administration and outpatient treatment.
List Of Key Companies Profiled In Injectable Drug Delivery Market:
- BD (New Jersey, U.S)
- SHL Medical AG (Switzerland, Europe)
- Schott AG (Germany, Europe)
- West Pharmaceutical Services, Inc. (Pennsylvania, U.S)
- Pfizer Inc. (New York, U.S)
- Insulet Corporation (Massachusetts, U.S)
- Elcam Medical (Israel, Middle East)
- Eli Lilly and Company (Indiana, U.S)
- Ypsomed AG (Switzerland, Europe)
- Gerresheimer AG (Germany, Europe)